Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Biochemical Pharmaceutics ; (6): 56-57, 2017.
Artículo en Chino | WPRIM | ID: wpr-659818

RESUMEN

Objective To analyse the effect of clarithromycin omeprazole in patients with chronic gastritis after treatment. Methods 100 cases of chronic gastritis in Ningbo Yinzhou People's Hospital (January 2016 to January 2017) were selected and divided into 2 groups according to the principle of computer randomization. One group was treated with omeprazole (control group) and the other group was treated with clarithromycin (observation group). Comparison of the total effective rate of 2 groups, relapse, the occurrence of adverse reactions and so on. Results In the observation group, the total effective rate was 90.00% and the recurrence probability was 2.00 % after treatment. The indexes were improved, compared with the control group (70.00 % and 16.00 %, respectively) Dominant position (P<0.05). However, the probability of adverse events in the two groups was not significantly different, which was 8.00% vs 10.00 %. Conclusion The use of omeprazole on the basis of the treatment of patients with chronic gastritis and then combined with the treatment of clarithromycin, the effect is more ideal.

2.
Chinese Journal of Biochemical Pharmaceutics ; (6): 56-57, 2017.
Artículo en Chino | WPRIM | ID: wpr-657577

RESUMEN

Objective To analyse the effect of clarithromycin omeprazole in patients with chronic gastritis after treatment. Methods 100 cases of chronic gastritis in Ningbo Yinzhou People's Hospital (January 2016 to January 2017) were selected and divided into 2 groups according to the principle of computer randomization. One group was treated with omeprazole (control group) and the other group was treated with clarithromycin (observation group). Comparison of the total effective rate of 2 groups, relapse, the occurrence of adverse reactions and so on. Results In the observation group, the total effective rate was 90.00% and the recurrence probability was 2.00 % after treatment. The indexes were improved, compared with the control group (70.00 % and 16.00 %, respectively) Dominant position (P<0.05). However, the probability of adverse events in the two groups was not significantly different, which was 8.00% vs 10.00 %. Conclusion The use of omeprazole on the basis of the treatment of patients with chronic gastritis and then combined with the treatment of clarithromycin, the effect is more ideal.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA